Opinion|Videos|July 30, 2026
Medication Access, Financial Navigation, and Care Transitions
In this episode, Ali tackles the operational barriers that prevent patients from starting menin inhibitors despite being approved.
Advertisement
Episodes in this series
In this episode, Ali tackles the operational barriers that prevent patients from starting menin inhibitors despite being approved. He shares strategies for prior authorization success, timely manufacturer hub enrollment, insurance-driven copay navigation, and adherence escalation protocols—plus reveals the most common gaps when patients transition from academic centers to community pharmacy.
Advertisement
Related to this article
Before lung cancer therapy begins, diagnostic findings and treatment readiness shape care, creating opportunities for pharmacists to help patients start safely.
October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial.
October’s hematology coverage highlighted first-line pirtobrutinib, questions about myeloma treatment duration and early intervention, and pharmacists’ roles in medication safety and access.
October’s oncology coverage highlighted new treatment options in rectal, breast, and prostate cancers, alongside longer-term survival findings and concerns about reduced-frequency immunotherapy.
Young adults who vaped daily but never smoked had lower flow-mediated dilation and peak oxygen uptake than peers who used neither product.
ESMO 2026 lung cancer trials reshape first-line care with tarlatamab maintenance, stronger KRAS G12C results, and TROP2 ADC gains, raising pharmacy monitoring demands.
Advertisement
Advertisement
Trending on Pharmacy Times
1
October 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
2
Over Half of RSV-Related Deaths in Hospitalized Adults Occur After Discharge
3
Full IDWeek Data Highlights 31-Valent Pneumococcal Conjugate Vaccine Candidate in Adults
4
Nicotine Vaping Linked to Lower Vascular Function in Young Adults
5